Chile vs Tajikistan: The number of people with susceptibility test result for rifampicin
Chile
1,772
in 2021
Tajikistan
1,862
in 2021
Chile rank
53rd
Tajikistan rank
50th
The number of people with susceptibility test result for rifampicin over time
- Chile
- Tajikistan
How they compare
Tajikistan currently reports 1,862 against 1,772 in Chile, a difference of 90.
That makes Tajikistan's figure about 1.1 times Chile's.
Across all 5 years both countries report, Tajikistan has been ahead every year.
Chile ranks 53rd and Tajikistan ranks 50th of 155 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,721 | 2,412 | 691.67 | Tajikistan |
| 2020s | 1,641 | 1,772 | 131.5 | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Chile or Tajikistan?
- Tajikistan, at 1,862 against 1,772 in Chile as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Chile and Tajikistan?
- 90, with Tajikistan ahead.
- How many years of comparable data are there for Chile and Tajikistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Chile and Tajikistan rank globally for the number of people with susceptibility test result for rifampicin?
- Chile ranks 53rd and Tajikistan ranks 50th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.